Literature DB >> 6304275

Sequelae of maternally derived cytomegalovirus infections in premature infants.

A S Yeager, P E Palumbo, N Malachowski, R L Ariagno, D K Stevenson.   

Abstract

Eighteen of 106 (17%) infants of seropositive mothers, with birth weights less than 1500 gm, acquired cytomegalovirus from a maternal source. Neutropenia, lymphocytosis, thrombocytopenia, and hepatosplenomegaly developed in some infants concomitant with the onset of CMV excretion. Infected infants who excreted CMV at less than 7 weeks of age had longer oxygen requirements than infants who did not excrete CMV until they were older. Passively derived maternal antibody to CMV fell more rapidly over the first few months of life in sick premature infants than would be expected in term infants. Among six infected premature infants, five had undetectable antibody titers when CMV excretion began. Loss of passively acquired antibody and early excretion of virus appear to be associated with symptomatic CMV infections in premature infants of seropositive mothers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304275     DOI: 10.1016/s0022-3476(83)80025-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Cytomegalovirus transmission from breast milk in premature babies: does it matter?

Authors:  P Bryant; C Morley; S Garland; N Curtis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

2.  Comparison of the Vitek Immunodiagnostic Assay System with three immunoassay systems for detection of cytomegalovirus-specific immunoglobulin G.

Authors:  D K Hopson; A C Niles; P R Murray
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study.

Authors:  Maik Dorn; Karen Lidzba; Andrea Bevot; Rangmar Goelz; Till-Karsten Hauser; Marko Wilke
Journal:  Hum Brain Mapp       Date:  2013-09-11       Impact factor: 5.038

4.  Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes.

Authors:  Sagori Mukhopadhyay; Sarah A Meyer; Sallie R Permar; Karen M Puopolo
Journal:  Am J Perinatol       Date:  2016-04-08       Impact factor: 1.862

5.  Detection of cytomegalovirus antibody by enzyme immunoassay and lack of evidence for an effect resulting from strain heterogeneity.

Authors:  S P Adler; M McVoy
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

6.  Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.

Authors:  Elizabeth P Ehlinger; Emily M Webster; Helen H Kang; Aislyn Cangialose; Adam C Simmons; Kimberly H Barbas; Sandra K Burchett; Mary L Gregory; Karen M Puopolo; Karen P Puopolo; Sallie R Permar
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

7.  Use of ganciclovir in the treatment of acquired cytomegalovirus disease in a preterm infant.

Authors:  H Amin; T Jadavji; R Sauve; J Gill
Journal:  Can J Infect Dis       Date:  1990

8.  Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants.

Authors:  Johannes Meier; Uta Lienicke; Edda Tschirch; Detlev H Krüger; Roland R Wauer; Susanna Prösch
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Guidelines for transfusion of erythrocytes to neonates and premature infants. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-12-15       Impact factor: 8.262

10.  Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.

Authors:  Ai-Rhan Ellen Kim; Yeon Kyung Lee; Kyung Ah Kim; Young Kyu Chu; Byung Yoon Baik; Eun Soon Kim; Sung Cheol Yun; Ki Soo Kim; Soo Young Pi
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.